Molecure S.A. (WSE: MOC)
Poland
· Delayed Price · Currency is PLN 11.02
+1.24 (12.58%)
Nov 20, 2024, 2:45 PM CET
Molecure Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Operating Revenue | 1.05 | 3.65 | 7.51 | 1.17 | 124.91 | 2.01 | Upgrade
|
| Other Revenue | 0.47 | - | - | - | - | - | Upgrade
|
| Revenue | 1.52 | 3.65 | 7.51 | 1.17 | 124.91 | 2.01 | Upgrade
|
| Revenue Growth (YoY) | -83.61% | -51.39% | 543.32% | -99.06% | 6100.72% | 45.76% | Upgrade
|
| Cost of Revenue | 3.24 | 4.1 | 5.06 | 2.77 | 38.41 | 0.15 | Upgrade
|
| Gross Profit | -1.72 | -0.45 | 2.45 | -1.61 | 86.5 | 1.87 | Upgrade
|
| Selling, General & Admin | 25.63 | 27.98 | 34.39 | 8.99 | 12.21 | 4.28 | Upgrade
|
| Other Operating Expenses | 0.96 | 0.92 | 1.31 | 0.03 | 0.37 | 0.78 | Upgrade
|
| Operating Expenses | 30.18 | 31.73 | 40.12 | 12.16 | 12.8 | 6.69 | Upgrade
|
| Operating Income | -31.9 | -32.18 | -37.67 | -13.76 | 73.7 | -4.83 | Upgrade
|
| Interest Expense | -0.05 | -0.04 | -0.02 | -0.01 | -0 | -0 | Upgrade
|
| Interest & Investment Income | 1.68 | 4.39 | 1.91 | 0 | 0.14 | 0.74 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.22 | -0.54 | -0.07 | 0.13 | -0.17 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.27 | -0 | -0.1 | -0 | -0.02 | -0.08 | Upgrade
|
| EBT Excluding Unusual Items | -30.75 | -28.37 | -35.95 | -13.64 | 73.65 | -4.17 | Upgrade
|
| Pretax Income | -30.75 | -28.37 | -35.95 | -13.64 | 73.65 | -4.17 | Upgrade
|
| Income Tax Expense | - | - | - | - | 5.69 | - | Upgrade
|
| Net Income | -30.75 | -28.37 | -35.95 | -13.64 | 67.96 | -4.17 | Upgrade
|
| Net Income to Common | -30.75 | -28.37 | -35.95 | -13.64 | 67.96 | -4.17 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 14 | 14 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 14 | 14 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | 4.35% | 20.00% | 0.56% | 2.59% | -0.51% | -0.08% | Upgrade
|
| EPS (Basic) | -1.83 | -1.69 | -2.56 | -0.98 | 5.00 | -0.30 | Upgrade
|
| EPS (Diluted) | -1.83 | -1.69 | -2.56 | -0.98 | 5.00 | -0.30 | Upgrade
|
| Free Cash Flow | -33.63 | -23.65 | -37.45 | -15.95 | 55.35 | -7.47 | Upgrade
|
| Free Cash Flow Per Share | -2.00 | -1.40 | -2.67 | -1.14 | 4.07 | -0.55 | Upgrade
|
| Gross Margin | -112.84% | -12.29% | 32.64% | -137.47% | 69.25% | 92.71% | Upgrade
|
| Operating Margin | -2096.05% | -880.99% | -501.37% | -1178.54% | 59.01% | -239.60% | Upgrade
|
| Profit Margin | -2020.94% | -776.78% | -478.49% | -1167.58% | 54.41% | -206.79% | Upgrade
|
| Free Cash Flow Margin | -2209.72% | -647.54% | -498.43% | -1365.60% | 44.31% | -370.91% | Upgrade
|
| EBITDA | -30.11 | -30.28 | -35.82 | -12.73 | 74.99 | -3.74 | Upgrade
|
| EBITDA Margin | - | - | - | - | 60.03% | -185.55% | Upgrade
|
| D&A For EBITDA | 1.79 | 1.9 | 1.85 | 1.04 | 1.29 | 1.09 | Upgrade
|
| EBIT | -31.9 | -32.18 | -37.67 | -13.76 | 73.7 | -4.83 | Upgrade
|
| EBIT Margin | - | - | - | - | 59.01% | -239.60% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 7.73% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.